Taysha Gene Therapies, Inc. (TSHA)

5.25 -0.25 (-4.55%) USD  |  NASDAQ  |  Jan 02, 15:34
More

Taysha Gene Therapies EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for TSHA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
AngioDynamics, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade
Bolt Biotherapeutics, Inc. Upgrade
Neurogene, Inc. Upgrade
Aspire Biopharma Holdings, Inc. Upgrade